Published in Frontiers in Neurology – 2020
Authors: Jorge Jacinto, Pasquale Varriale, Emilie Pain, Andreas Lysandropoulos and Alberto Esquenazi
Botulinum toxin-A (BoNT-A) injections are first-line treatment for adult spasticity. Prior patient surveys have reported that BoNT-A treatment improves quality of life but that symptoms usually recur before the next injection.
Objective: The objective of this study was to explore, in-depth, patient perceptions of the impact of spasticity and the waning of BoNT-A therapeutic effects.